Virtual Exercise Rehabilitation Treatment Program for Post Exacerbation of Chronic Obstructive Pulmonary Disease

COPD Clinical Trial

— VERTEX  

Official title:

Virtual Exercise Rehabilitation Treatment Program for Post Exacerbation of Chronic Obstructive Pulmonary Disease

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05045209
• Other study ID #: 13451
• Status: Recruiting
• Start date: January 1, 2022
• Est. completion date: October 1, 2023

Study information

• Verified date: November 2022
• Source: St. Joseph's Healthcare Hamilton
• Contact: Natya Raghavan, MDCM
• Phone: 905-521-2100
• Email: raghanat[@]hhsc.ca
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Respiratory rehabilitation is an intervention proven to improve quality of life in those with chronic lung disease but access remains poor. The investigators will assess the feasibility and acceptability of a virtual platform for respiratory rehabilitation as an alternative to in person rehabilitation. The aim is to use the technology in those post admission with COPD where access has been even more of a challenge as during this period patients find it difficult to access an out patient program due to their frailty.

Description:

People living with lung disease struggle with activities. An exercise program can help but these programs are limited and are hard to get to and generally have a long wait list. The investigators will offer exercise and education through a tablet with internet provided 2 times per week for 10 weeks for patients admitted to hospital with a worsening of their COPD. Patients will work with a trained therapist for the exercise sessions and with the team for the education sessions. The investigators will assess outcomes on functional and quality of life improvements as well as feasibility and scalability of the technology.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 40
• Est. completion date: October 1, 2023
• Est. primary completion date: March 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 90 Years

Eligibility

Inclusion Criteria:

• minimum age of 18 years

• maximum age of 90 years

• diagnosis of COPD

Exclusion Criteria:

• inability to perform exercise

• severe debilitating conditions

Related Conditions & MeSH terms

• COPD
• Lung Diseases, Obstructive
• Pulmonary Disease, Chronic Obstructive

Intervention

Other:
• Virtual rehabilitation
Patient who are assigned to this group will receive virtual rehabilitation

Locations

Country	Name	City	State
Canada	St. Josephs' Hospital, Hamilton	Hamilton	Ontario

Sponsors (2)

Lead Sponsor	Collaborator
St. Joseph's Healthcare Hamilton	Boeringer Ingelheim

Country where clinical trial is conducted

Canada, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Daily activity levels	Measured by step counts	1 year
Primary	6 minute walk test distance	The distance walked during the 6 minute	1 year
Primary	1-MSTST	One-minute sit to stand test	1 year